Patrice P. Rioux

Patrice Rioux serves as the Chief Executive Officer of Thiogenesis Therapeutics, Corp. since March 2022 and as President of pRx Consulting, LLC since June 2004, specializing in drug development, medical/regulatory affairs, and clinical operations. Previous roles include Head of Clinical Development at CIPLA TECHNOLOGIES AND INNOVATION PRIVATE LIMITED and Chief Medical Officer for Raptor Pharmaceutical, Ferrokin Biosciences, Inc., and Edison Pharmaceuticals, Inc., overseeing clinical operations and regulatory affairs. Significant achievements include designing a non-inferiority phase 3 trial for a rare disease and submitting regulatory documents that led to FDA approval and orphan exclusivity. Additional experience encompasses medical directorships and research from Biogen and INSERM, with educational credentials including an MD in Medicine, a Ph.D. in Mathematical Statistics, and a Masters in Pharmacology from prestigious Paris institutions.